dc.contributor.author | Canatan, D. | |
dc.contributor.author | Bilgen, Türker | |
dc.contributor.author | Çiftçi, V. | |
dc.contributor.author | Yazıcı, G. | |
dc.contributor.author | Delibaş, S. | |
dc.contributor.author | Keser, İ. | |
dc.date.accessioned | 2022-05-11T14:48:08Z | |
dc.date.available | 2022-05-11T14:48:08Z | |
dc.date.issued | 2016 | |
dc.identifier.issn | 1300-7777 | |
dc.identifier.uri | https://doi.org/10.4274/tjh.2015.0299 | |
dc.identifier.uri | https://hdl.handle.net/20.500.11776/10604 | |
dc.description.abstract | [No abstract available] | en_US |
dc.language.iso | eng | en_US |
dc.publisher | Turkish Society of Hematology | en_US |
dc.identifier.doi | 10.4274/tjh.2015.0299 | |
dc.rights | info:eu-repo/semantics/openAccess | en_US |
dc.subject | Abnormal hemoglobins | en_US |
dc.subject | Hemoglobin fontainebleau | en_US |
dc.subject | Hemoglobin G-Waimanalo | en_US |
dc.subject | DNA | en_US |
dc.subject | hemoglobin beta chain | en_US |
dc.subject | hemoglobin fontainebleau | en_US |
dc.subject | hemoglobin g Waimanalo | en_US |
dc.subject | hemoglobin variant | en_US |
dc.subject | unclassified drug | en_US |
dc.subject | codon | en_US |
dc.subject | hemoglobin alpha chain | en_US |
dc.subject | hemoglobin Fontainebleau | en_US |
dc.subject | hemoglobin G Waimanalo | en_US |
dc.subject | hemoglobin variant | en_US |
dc.subject | adult | en_US |
dc.subject | alpha gene A1 | en_US |
dc.subject | alpha gene A2 | en_US |
dc.subject | blood analysis | en_US |
dc.subject | blood cell count | en_US |
dc.subject | case report | en_US |
dc.subject | DNA sequence | en_US |
dc.subject | female | en_US |
dc.subject | gene | en_US |
dc.subject | gene mutation | en_US |
dc.subject | hematologic disease | en_US |
dc.subject | high performance liquid chromatography | en_US |
dc.subject | human | en_US |
dc.subject | Letter | en_US |
dc.subject | normochromic normocytic anemia | en_US |
dc.subject | polymerase chain reaction | en_US |
dc.subject | thalassemia | en_US |
dc.subject | Turk (people) | en_US |
dc.subject | alpha-Thalassemia | en_US |
dc.subject | asymptomatic disease | en_US |
dc.subject | codon | en_US |
dc.subject | genetics | en_US |
dc.subject | missense mutation | en_US |
dc.subject | point mutation | en_US |
dc.subject | Turkey | en_US |
dc.subject | Adult | en_US |
dc.subject | alpha-Globins | en_US |
dc.subject | alpha-Thalassemia | en_US |
dc.subject | Asymptomatic Diseases | en_US |
dc.subject | Chromatography, High Pressure Liquid | en_US |
dc.subject | Codon | en_US |
dc.subject | Female | en_US |
dc.subject | Hemoglobins, Abnormal | en_US |
dc.subject | Humans | en_US |
dc.subject | Mutation, Missense | en_US |
dc.subject | Point Mutation | en_US |
dc.subject | Turkey | en_US |
dc.title | First observation of hemoglobin G-waimanalo and hemoglobin fontainebleau cases in the Turkish population | en_US |
dc.title.alternative | Türk toplumunda gözlenen ilk hemoglobin g-waimanalo ve hemoglobin fontainebleau olguları] | en_US |
dc.type | letter | en_US |
dc.relation.ispartof | Turkish Journal of Hematology | en_US |
dc.department | Rektörlüğe Bağlı Bölümler, Rektörlük, Bilimsel ve Teknolojik Araştırmalar Uygulama ve Araştırma Merkezi | en_US |
dc.identifier.volume | 33 | en_US |
dc.identifier.issue | 1 | en_US |
dc.identifier.startpage | 71 | en_US |
dc.identifier.endpage | 72 | en_US |
dc.institutionauthor | Bilgen, Türker | |
dc.relation.publicationcategory | Diğer | en_US |
dc.authorscopusid | 6701448163 | |
dc.authorscopusid | 9242258800 | |
dc.authorscopusid | 57130822200 | |
dc.authorscopusid | 57130497800 | |
dc.authorscopusid | 57130808000 | |
dc.authorscopusid | 6701531346 | |
dc.identifier.scopus | 2-s2.0-84958787178 | en_US |
dc.identifier.pmid | 27020723 | en_US |